K. Hornslien

发表

Randomized phase II trial comparing twice daily hyperfractionated with once daily hypofractionated thoracic radiotherapy in limited disease small cell lung cancer

R. Bremnes, O. Brustugun, B. Grønberg, 2016, Acta oncologica.

Vinorelbine and gemcitabine vs vinorelbine and carboplatin as first-line treatment of advanced NSCLC. A phase III randomised controlled trial by the Norwegian Lung Cancer Study Group

R. Bremnes, T. Amundsen, T. Wentzel‐Larsen, 2012, British Journal of Cancer.

Gender effects on quality of life and symptom burden in patients with lung cancer: results from a prospective, cross-cultural, multi-center study

M. Hjermstad, A. Bottomley, M. Koller, 2020, Journal of thoracic disease.

Cardiorespiratory fitness in relation to self-reported physical function in cancer patients after chemotherapy.

S. Fosså, S. Strømme, M. Hjermstad, 2006, The Journal of sports medicine and physical fitness.

An international study to revise the EORTC questionnaire for assessing quality of life in lung cancer patients

M. Hjermstad, A. Bottomley, M. Koller, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Long-term follow-up of cancer patients receiving radiotherapy for bone metastases: results from a randomised multicentre trial.

S. Kaasa, R. Bremnes, J. Lund, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Effectiveness of physical activity on cardiorespiratory fitness and health-related quality of life in young and middle-aged cancer patients shortly after chemotherapy.

S. Fosså, S. Strømme, E. Skovlund, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

An international field study to investigate the psychometric properties of the updated EORTC QLQ-LC29 module for assessing quality of life in patients with lung cancer

M. Hjermstad, A. Bottomley, W. Chie, 2021 .

Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study.

M. Hjermstad, A. Bottomley, M. Koller, 2020, The Lancet. Oncology.

High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial.

O. Brustugun, J. Nyman, S. Langer, 2021, The Lancet. Oncology.

Potentially curative radiotherapy for non-small-cell lung cancer in Norway: a population-based study of survival.

R. Bremnes, T. Strand, Mari Wang, 2011, International journal of radiation oncology, biology, physics.

Randomized phase III trial comparing switch-maintenance pemetrexed with observation followed by pemetrexed at progression in advanced NSCLC

O. Brustugun, S. Sørhaug, B. Grønberg, 2020, Acta oncologica.

An international study to revise the EORTC questionnaire for assessing quality of life in lung cancer patients.

M. Hjermstad, A. Bottomley, M. Koller, 2017 .

Effectiveness after 1 year of a short-term physical activity intervention on cardiorespiratory fitness in cancer patients.

S. Fosså, E. Skovlund, A. Dahl, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term follow-up of cancer patients receiving radiotherapy for bone metastases: results from a randomised multicentre trial.

S. Kaasa, R. Bremnes, J. Lund, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.